In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin.
Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital.
Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today’s rapidly evolving diagnostic landscape.
All content for The SHEA Podcast is the property of The SHEA Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin.
Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital.
Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today’s rapidly evolving diagnostic landscape.
Preventing Transmission at the Port-of-Entry: Risk Reduction Practices in the ED
The SHEA Podcast
33 minutes 13 seconds
1 year ago
Preventing Transmission at the Port-of-Entry: Risk Reduction Practices in the ED
This is the final episode of SHEA's three-part series, Developments in Transmission-based Precautions. This discussion focuses on the common workflows in the ED and the limitations associated with infection prevention practices when compared to other settings. Speakers will address opportunities to improve infection prevention identified during the pandemic, as well as screening of patients, use of personal protective equipment (PPE), and pathogen versus syndrome-based transmission-based precautions.
Speakers:
John Townes, MD
Anna Quay Yaffee, MD, MPH
Moderator:
Chad Nix, MSc, CIC
The SHEA Podcast
In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin.
Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital.
Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today’s rapidly evolving diagnostic landscape.
